Mizuho Markets Americas »

Halozyme Therapeutics shares owned by Mizuho Markets Americas

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Mizuho Markets Americas from 13F filings

Historical chart of Mizuho Markets Americas investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Mizuho Markets Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Mizuho Markets Americas

Quarter filed Position value Share count Share price at filing
2024-03-31 $19M 457k 40.68
2023-12-31 $17M 447k 36.96
2023-09-30 $15M 403k 38.20
2023-06-30 $15M 403k 36.07
2023-03-31 $14M 359k 38.19
2022-12-31 $16M 275k 56.90
2022-09-30 $14M 359k 39.54